Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint-Reference-Cited by-同舟云学术

Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint

Published:2006-12 Issue:6 Volume:10 Page:473-486
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Bruno Tiziana,De Nicola Francesca,Iezzi Simona,Lecis Daniele,D'Angelo Carmen,Di Padova Monica,Corbi Nicoletta,Dimiziani Leopoldo,Zannini Laura,Jekimovs Christian,Scarsella Marco,Porrello Alessandro,Chersi Alberto,Crescenzi Marco,Leonetti Carlo,Khanna Kum Kum,Soddu Silvia,Floridi Aristide,Passananti Claudio,Delia Domenico,Fanciulli Maurizio

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference48 articles.

1. Enhanced phosphorylation of p53 by ATM in response to DNA damage;Banin;Science,1998

2. Mammalian G1- and S-phase checkpoints in response to DNA damage;Bartek;Curr. Opin. Cell Biol.,2001

3. Chk1 and Chk2 kinases in checkpoint control and cancer;Bartek;Cancer Cell,2003

4. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis;Bartkova;Nature,2005

5. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome;Bell;Science,1999

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance;Molecular Biology Reports;2024-02-17

2. Apoptosis-inducing, anti-angiogenic and anti-migratory effects of a dinuclear Pd(II) complex on breast cancer: A promising novel compound;Microvascular Research;2024-01

3. Apoptosis antagonizing transcription factor‐mediated liver damage and inflammation to cancer: Therapeutic intervention by curcumin in experimental metabolic dysfunction associated steatohepatitis‐hepatocellular carcinoma;Journal of Cellular Physiology;2023-11-09

4. AATF/Che-1 RNA polymerase II binding protein overexpression reduces the anti-tumor NK-cell cytotoxicity through activating receptors modulation;Frontiers in Immunology;2023-06-26

5. Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies;MedComm;2023-05-28